EcoDrugPlus

Adrenoceptor Alpha 1a

Ensembl ID : ENSMOCG00000018438
Gene Symbol: ADRA1A
3 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSMOCG00000008511
Gene Symbol: ADRA1B
3 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSMOCG00000006284
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSMOCG00000022188
Gene Symbol: ADRA2A
3 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSMOCG00000002034
Gene Symbol: ADRA2B
3 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMOCG00000006396
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSMOCG00000003073
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSMOCG00000002446
Gene Symbol: ADRB2
3 Cross references
263 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSMOCG00000022815
Gene Symbol: AGER
3 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase Class-3

Ensembl ID : ENSMOCG00000006666
Gene Symbol: LOC101981098
2 Cross references
399 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSMOCG00000000854
Gene Symbol: AKR1B1
3 Cross references
429 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]

Ensembl ID : ENSMOCG00000018524
Gene Symbol: LOC101996366
3 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).